These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16900153)

  • 1. The science-business tango. Interview by Mari Paul.
    Hirth P
    Nat Biotechnol; 2006 Aug; 24(8):1035-6. PubMed ID: 16900153
    [No Abstract]   [Full Text] [Related]  

  • 2. Celgene samples from science smorgasbord.
    Mullard A
    Nat Biotechnol; 2015 Sep; 33(9):892-3. PubMed ID: 26348944
    [No Abstract]   [Full Text] [Related]  

  • 3. Management consulting for scientists.
    Kulkarni S
    Nat Biotechnol; 2007 Dec; 25(12):1489-90. PubMed ID: 18066046
    [No Abstract]   [Full Text] [Related]  

  • 4. Mission possible: managing innovation in drug discovery.
    Zhong X; Moseley GB
    Nat Biotechnol; 2007 Aug; 25(8):945-6. PubMed ID: 17687373
    [No Abstract]   [Full Text] [Related]  

  • 5. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 6. Nanomedicine lacks recognition in Europe.
    Moran N
    Nat Biotechnol; 2006 Feb; 24(2):121. PubMed ID: 16465142
    [No Abstract]   [Full Text] [Related]  

  • 7. Achieving better healthcare through diverse leadership. Interview by Mari Paul.
    Ramamoorthy P
    Nat Biotechnol; 2011 Jul; 29(7):665-6. PubMed ID: 21747389
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyseq-Variagenics merger signals end of the line.
    Hodgson J
    Nat Biotechnol; 2003 Jan; 21(1):5. PubMed ID: 12511895
    [No Abstract]   [Full Text] [Related]  

  • 9. Growing against the grain.
    Boyle M
    Fortune; 2004 May; 149(9):148-9, 152, 154 passim. PubMed ID: 15124331
    [No Abstract]   [Full Text] [Related]  

  • 10. Is Elan a turnaround?
    Jacobs T
    Nat Biotechnol; 2003 Sep; 21(9):985. PubMed ID: 12949557
    [No Abstract]   [Full Text] [Related]  

  • 11. Paths to entrepreneurship in the life sciences.
    Mehta S
    Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
    [No Abstract]   [Full Text] [Related]  

  • 12. For success, focus your strengths.
    Levinson AD
    Nat Biotechnol; 1998 May; 16 Suppl():45-6. PubMed ID: 9591268
    [No Abstract]   [Full Text] [Related]  

  • 13. Anthony Coyle.
    Coyle A
    Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
    [No Abstract]   [Full Text] [Related]  

  • 14. Elias Zerhouni.
    Zerhouni E
    Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
    [No Abstract]   [Full Text] [Related]  

  • 15. [Galderma relies on partnerships].
    Fournier F
    J Dtsch Dermatol Ges; 2003 Jan; 1(1):83. PubMed ID: 16285297
    [No Abstract]   [Full Text] [Related]  

  • 16. Profile: Corey Goodman.
    Kling J
    Nat Biotechnol; 2009 Apr; 27(4):308. PubMed ID: 19352358
    [No Abstract]   [Full Text] [Related]  

  • 17. Leading biotechnology companies quit the IBA.
    Gershon D
    Nature; 1990 Apr; 344(6266):481. PubMed ID: 2320118
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it too late to save Schering?
    Simons J
    Fortune; 2003 Sep; 148(5):145-6, 148, 150. PubMed ID: 14509911
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons on ethical decision making from the bioscience industry.
    Mackie JE; Taylor AD; Finegold DL; Daar AS; Singer PA
    PLoS Med; 2006 May; 3(5):e129. PubMed ID: 16573361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The seven deadly sins of business development.
    Stewart JJ; Bonifant B
    Nat Biotechnol; 2008 Apr; 26(4):375-7. PubMed ID: 18404814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.